Millipede Medical Acquired By Boston Scientific
Santa Rosa-based Millipede Medical, which makes transcatheter annuioplasty rings for treating mitral regurgitation, has been acquired by Boston Scientific, in a deal worth $325M, with a possible earnout of $125M more. Boston Scientific was already an investor in Millipede Medical, having invested $90M in the company in January of 2018. Randy Lashinski is co-founder and CEO of Millipede.
posted on Wednesday, January 2, 2019
Related companies:
Millipede, Inc.
Related stories:
> Sadra Medical Acquired By Boston Scientific
> Saints Capital Buys Portfolio From Boston Scientific
> Asthmatx Acquired By Boston Scientific
> SV Life Sciences Names Venture Partner
> Sadra Medical Raises $19M
silicontap.com Home